Patent · US Expired

5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors

US6599902B2 · kind B2 · utility

5Cited by
25References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 2002
Grant dateJul 29, 2003
Priority date
Expiry dateMay 30, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to certain 5-aralkylsulfonyl-3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives that inhibit kinases, in particular met kinase. Pharmaceutical compositions comprising these compounds, methods of treating diseases mediated by kinases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing them are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.